ArticleJournal of pharmaceutical policy and practice2023

Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach.

Raymond H Henderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.